Skip to Main Content

Paper Details

Early non-neutralizing, afucosylated antibody responses are associated with COVID-19 severity.
Sci Transl Med
65
2022
Afucosylated IgG immune complexes, COVID-, COVID-19, Fc, Fc-gamma receptor, IgG, SARS-CoV, SARS-CoV-2, afucosylated IgG immune complexes, afucosylated immunoglobulin G (IgG), coronavirus disease 2019, human, human IgG, immune cells, inflammation, messenger RNA, patients, severe acute respiratory syndrome coronavirus, severe acute respiratory syndrome coronavirus 2
Author NameAffiliation
Seunghee Kim-SchulzePrecision Immunology Institute, Icahn School of Medicine at Mount Sinai
Seunghee Kim-SchulzePrecision Immunology Institute, Icahn School of Medicine at Mount Sinai
Sacha GnjaticPrecision Immunology Institute, Icahn School of Medicine at Mount Sinai
Sacha GnjaticPrecision Immunology Institute, Icahn School of Medicine at Mount Sinai
Sacha GnjaticIcahn School of Medicine at Mount Sinai
Sacha GnjaticTisch Cancer Institute, Icahn School of Medicine at Mount Sinai
Sacha GnjaticPrecision Immunology Institute, Icahn School of Medicine at Mount Sinai
Sacha GnjaticTisch Cancer Institute, Icahn School of Medicine at Mount Sinai
Sacha GnjaticIcahn School of Medicine at Mount Sinai
Sacha GnjaticPrecision Immunology Institute, Icahn School of Medicine at Mount Sinai
Miriam MeradPrecision Immunology Institute, Icahn School of Medicine at Mount Sinai
Miriam MeradPrecision Immunology Institute, Icahn School of Medicine at Mount Sinai
Miriam MeradIcahn School of Medicine at Mount Sinai
Miriam MeradTisch Cancer Institute, Icahn School of Medicine at Mount Sinai
Miriam MeradPrecision Immunology Institute, Icahn School of Medicine at Mount Sinai
Miriam MeradTisch Cancer Institute, Icahn School of Medicine at Mount Sinai
Miriam MeradIcahn School of Medicine at Mount Sinai
Miriam MeradPrecision Immunology Institute, Icahn School of Medicine at Mount Sinai
Prabhu S ArunachalamInstitute for Immunity, Stanford University School of Medicine
Scott D BoydStanford University School of Medicine
Mark M DavisInstitute for Immunity, Stanford University School of Medicine
Mark M DavisHoward Hughes Medical Institute, Stanford University School of Medicine
Mark M DavisStanford University School of Medicine
Holden T MaeckerInstitute for Immunity, Stanford University School of Medicine
Bali PulendranInstitute for Immunity, Stanford University School of Medicine
Bali PulendranInstitute for Immunity, Stanford University School of Medicine
Paul J UtzStanford University School of Medicine
  • 1 - 27

Datasets

Release 1.2